SS
Shipra Srivastava
About Shipra Srivastava
Data last updated:
Shipra Srivastava is a Designated Partner at Auxilla Pharmaceuticals And Research Llp (since 2023), Director at Ursceal Pharma Private Limited (since 2019) and Designated Partner at Pharmaniqe Research And Investment Llp (since 2020). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹3.43 Cr; the largest is Auxilla Pharmaceuticals And Research Llp at ₹2.52 Cr (FY 2021). Earlier, Shipra Srivastava was a Director at Eiman Pharma Private Limited (2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 24 Nov 2023 | 2020 | ₹2.52 Cr (FY 2021) | Active | |
 Ursceal Pharma Private Limited U85110UP2019PTC117309 | Director | 24 May 2019 | 2019 | ₹91.2 Lakh (FY 2025) | Active |
| Designated Partner | 26 May 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Eiman Pharma Private Limited U85310UP2016PTC084991 | Director | 19 Jul 2016 | 2016 | ₹3.44 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shipra Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Kumar Labhendra Bhai Umrethia | 08739311 | Auxilla Pharmaceuticals And Research Llp , Pharmaniqe Research And Investment Llp | Designated Partner |
| Mohit Srivastava | 11073246 | Ursceal Pharma Private Limited | Director |
| Pratap Dinesh Singh | 10407728 | Ursceal Pharma Private Limited | Director |
| Manglesh Dhirubhai Desai | 00594298 | Pharmaniqe Research And Investment Llp | Designated Partner |
| Suchiben Patel | 08718704 | Pharmaniqe Research And Investment Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shipra Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shipra Srivastava
Shipra Srivastava currently holds 3 directorships: Auxilla Pharmaceuticals And Research Llp (Designated Partner, since 24 Nov 2023, revenue ₹2.52 Cr (FY 2021)); Ursceal Pharma Private Limited (Director, since 24 May 2019, revenue ₹91.2 Lakh (FY 2025)); Pharmaniqe Research And Investment Llp (Designated Partner, since 26 May 2020).
Shipra Srivastava was first appointed on 19 Jul 2016 as Director at Eiman Pharma Private Limited. The most recent appointment on record is 24 Nov 2023 at Auxilla Pharmaceuticals And Research Llp.
The 2 current companies of Shipra Srivastava that report revenue have a combined latest revenue of ₹3.43 Cr: Auxilla Pharmaceuticals And Research Llp ₹2.52 Cr (FY 2021); Ursceal Pharma Private Limited ₹91.2 Lakh (FY 2025).
Shipra Srivastava held 1 earlier board appointment: Eiman Pharma Private Limited (Director, 19 Jul 2016 to 16 Aug 2016).
The current boards of Shipra Srivastava's companies include Manish Kumar Labhendra Bhai Umrethia (Auxilla Pharmaceuticals And Research Llp), Mohit Srivastava (Ursceal Pharma Private Limited), Pratap Dinesh Singh (Ursceal Pharma Private Limited), Manglesh Dhirubhai Desai (Pharmaniqe Research And Investment Llp), Suchiben Patel (Pharmaniqe Research And Investment Llp).